Vancomycin

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Half-lifeThis section has been translated automatically.

5–6 h

Spectrum of actionThis section has been translated automatically.

Clostridium spp., Corynebacterium diphtheriae, Enterococcus spp., Staph. aureus, coagulase-negative staphylococci, Streptococcus spp.

IndicationThis section has been translated automatically.

Severe infections caused by staphylococci, streptococci and enterococci with resistance to other antibiotics or penicillin allergy. Infections of foreign bodies (e.g. endoprostheses), endocarditis, osteomyelitis and pneumonia (in combination with rifampicin, fosfomycin or gentamicin).

Limited indicationThis section has been translated automatically.

Breastfeeding.

Dosage and method of useThis section has been translated automatically.

  • Adults: 1-2 g/day in 2-4 ED each in 500 ml 5% glucose solution for at least 60 min. i.v.
  • Children: 20-40 mg/kg bw/day
  • infants and newborns: initial 15 mg/kg bw, maintenance dose during the first week of life 10 mg/kg every 12 hours, from the second week of life up to 1 month 10 mg/kg every 8 hours

Undesirable effectsThis section has been translated automatically.

Allergic reactions ( Red-Man-Syndrome)

Maculopapular exanthema

Erythema (exudative) multiforme

Stevens-Johnson syndrome

Toxic epidermal necrolysis.

Often eosinophilia, interstitial nephritis, fever, hearing disorders. If infusion is too fast, thrombophlebitis in the area of the infusion site.

Notice! In case of reduced renal function accumulation: nephrotoxicity and ototoxicity!

S.a. under AER: AER is the acronym for Vancomycin-resistant Enterococci. Vancomycin-resistant Enterococci are primarily recruited from the increasing reservoir of E. faecium isolates. They are mostly resistant to all glycopeptides.

InteractionsThis section has been translated automatically.

Caution in combination with ototoxic drugs.

ContraindicationThis section has been translated automatically.

Pre-damage of the vestibular or cochlear apparatus, pregnancy.

PreparationsThis section has been translated automatically.

Vancomycin Lilly, Vancomycin-ratiopharm, Vancomycin Abbott

LiteratureThis section has been translated automatically.

  1. Niikura T et al (2007) Vancomycin-impregnated calcium phosphate cement for methicillin-resistant Staphylococcus aureus femoral osteomyelitis. Orthopedics 30: 320-321

Authors

Last updated on: 29.10.2020